In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication. From 27 November 2020, the inhaled corticosteroid budesonide will be investigated as part of the UK’s national priority platform trial for Covid-19 treatments that can be taken at home. Led by the University of Oxford, […]
Innovative training to improve the safety of women and babies in low risk labour developed in the Thames Valley has won a national award. The initiative won the Patient Safety Innovation of the Year category at the HSJ Patient Safety Awards. It was also highly commended in the Education and Training category. The practical online programme is the […]
Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating the ChAdOx1 nCoV-2019 Oxford coronavirus vaccine. The trial will be hosted at KEMRI at its Kilifi based KEMRI-Wellcome Trust Research Programme, a longstanding collaboration between KEMRI, the University of Oxford and the Wellcome Trust […]
Oxford University Hospitals NHS Foundation Trust and IMPOWER Consulting have announced a collaborative working agreement in relation to improving impact to health and social care. The aim of the partnership is two-fold. Using its advanced capabilities in technology and digital, the Trust will work with IMPOWER to drive innovation that will benefit health and social […]
A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model – OpenABM-Covid19 – provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit […]
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19. The grant will accelerate the creation of the Covax-19® vaccine, which is being developed by Vaxine, an Australian biotechnology company focussing on the development of innovative […]
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psycho-social consequences of COVID-19. The researchers are inviting hospitals and […]
With support from Royal Philips, Oxford University Hospitals (OUH) NHS Foundation Trust has become one of the earliest UK adopters of a fully digitised cellular pathology (histopathology) department. OUH is one of the first NHS trusts in the country to achieve the milestone of digitising all surgical histology and referral slides within the cellular pathology department. This […]
Oxford University Hospitals (OUH) is one of the NHS trusts that will benefit from a £13.5m national funding boost to further enhance cellular pathology services and provide faster and more accurate diagnosis of deadly diseases such as cancer. The PathLAKE (Pathology Image Data Lake for Analytics Knowledge and Education) digital pathology consortium, led by University Hospital […]
The UNAIDS estimates that 38 million people currently live with human immunodeficiency virus (HIV) infection. Combination antiretroviral treatment has had great success in saving lives but is also associated with numerous medical and public health challenges. Vaccination remains the best and most cost-effective option for controlling HIV infection across the world. Professor Tomáš Hanke jointly […]